Malignant Pediatric Soft Tissue & Bone Tumors of the Extremities: A Retrospective Study
2 other identifiers
observational
163
1 country
1
Brief Summary
The aim of this study is to identify demographic \& disease characteristics in pediatric oncology patients diagnosed with soft tissue \& bone tumors involving the extremities \& treatment outcomes in these patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2016
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 21, 2015
CompletedFirst Posted
Study publicly available on registry
September 23, 2015
CompletedStudy Start
First participant enrolled
January 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedJanuary 10, 2020
January 1, 2020
3.8 years
September 21, 2015
January 7, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Overall survival (OS)
Time from the date of initiation of treatment until death from any cause
Participants will be retrospectively followed forward in time from the date of initiation of treatment till the primary completion date of the study, an expected average of 5 years
Event Free Survival (EFS)
Time from the date of initiation of treatment until disease progression, or death for any reason.
Participants will be retrospectively followed forward in time from the date of initiation of treatment till the primary completion date of the study, an expected average of 5 years
Eligibility Criteria
Pediatric cancer patients, those diagnosed with bone \& soft tissue neoplasms involving the extremities, in the period from 2000 January till 2015 December, and received treatment at the pediatric oncology department, their medical records will be retrospectively reviewed for data collection.
You may qualify if:
- Patients whose age less than 19 years.
- Patients diagnosed with bone \& soft tissue neoplasms involving the extremities.
You may not qualify if:
- Patients whose age more than 19 years.
- Patients diagnosed with bone \& soft tissue neoplasms not involving the extremities.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assiut University
Asyut, 71515, Egypt
Related Publications (3)
Bakotic, B. W. (2001).
BACKGROUNDCormier JN, Pollock RE. Soft tissue sarcomas. CA Cancer J Clin. 2004 Mar-Apr;54(2):94-109. doi: 10.3322/canjclin.54.2.94.
PMID: 15061599BACKGROUNDSondak, V. (2000).
BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer, Pediatric Oncology Department
Study Record Dates
First Submitted
September 21, 2015
First Posted
September 23, 2015
Study Start
January 1, 2016
Primary Completion
November 1, 2019
Study Completion
December 1, 2019
Last Updated
January 10, 2020
Record last verified: 2020-01